Sustained antimicrobial activity and reduced toxicity of oxidative biocides through biodegradable microparticles.

Authors:
Sofokleous P; Ali S; Wilson P; Buanz A; Gaisford S and 3 more

Journal:
Acta Biomater

Publication Year: 2017

DOI:
10.1016/j.actbio.2017.10.001

PMCID:
PMC5692019

PMID:
28986301

View on PubMed View on PMC View Publisher
Journal Information

Full Title: Acta Biomater

Abbreviation: Acta Biomater

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Biomedical Engineering

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
Flexible IrO<sub>x</sub> neural electrode for mouse vagus nerve stimulation.
Sun T; Tsaava T; Peragine J and 8 more (2023) - Transparency Score: 3/6
The cell-assembled extracellular matrix: A focus on the storage stability and terminal sterilizatio…
Potart D; Gluais M; Gaubert A and 6 more (2023) - Transparency Score: 3/6
An albumin-angiotensin converting enzyme 2-based SARS-CoV-2 decoy with FcRn-driven half-life extens…
Fuchs E; Rudnik-Jansen I; Dinesen A and 6 more (2022) - Transparency Score: 3/6
ROS-responsive polymer nanoparticles with enhanced loading of dexamethasone effectively modulate th…
Muhammad W; Zhu J; Zhai Z and 10 more (2022) - Transparency Score: 3/6
Single-injection COVID-19 subunit vaccine elicits potent immune responses.
Zhou X; Wang H; Luo Y and 3 more (2022) - Transparency Score: 3/6
View All Papers from This Journal
Transparency Score
2/6
0.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Disclosures Part of this project was funded by AGA Nanotech Ltd. UCL and AGA Nanotech Ltd hold patent applications relating to the technology described in the manuscript."

Evidence found in paper:

"Funding The project was funded by AGA Nanotech Ltd; a Wellcome Trust Institutional Strategic Support Fund contribution to the UCL Therapeutic Innovation Fund; UCL MRC Confidence in Concept scheme contribution and supported by the National Institute for Health Research University College London Hospitals Biomedical Research Centre and Higher Education Funding Council for England award under Critical Interventions in the UK Life Sciences Value Chain. A. Buanz is supported by EPSRC (Grant reference EP/K039229/1)."

Protocol Registration
Open Access
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025